TheEdgeResearch
Home / Stocks / REMLIFE.BO

Remedium Lifecare Ltd. (REMLIFE.BO)

BSE Consumer Cyclical Auto - Manufacturers
$0.85 ▲ +0.00%
Market Cap
$749.7M
Sector
Consumer Cyclical
Industry
Auto - Manufacturers
Beta
1.04
52-Wk Range
0.69-4.12
CEO
Adarsh Munjal
Country
IN
Currency
INR

Remedium Lifecare Ltd. operates in the Auto - Manufacturers industry of the Consumer Cyclical sector, headquartered in Mumbai, IN. The stock last traded at $0.85, up 0.00% on the session, giving a market capitalisation of $749.7M. Its beta of 1.04 implies it has historically moved more than the broad market.

Company profile
Exchange
Bombay Stock Exchange
Employees
7
IPO date
2018-05-25
Headquarters
Mumbai, IN
About Remedium Lifecare Ltd.

Remedium Lifecare Ltd. specializes in the distribution of essential raw materials crucial for Active Pharmaceutical Ingredient (API) manufacturing. This encompasses a range of inputs, including key starting materials (KSMs), critical raw materials (CRMs), and other foundational chemical components. Its product portfolio features substances such as Amino isophthalic Acid, Tellurium IV Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, and Trimethyl Sulfoxonium Iodide (TMSI). Established on February 19, 1988, the firm operates from its headquarters in Mumbai, India.

Comparable companies

Remedium Lifecare Ltd. is most often compared with the following Consumer Cyclical names:

RELCHEMQ.BOSAMKRG.BOSPLIL.BOSPLIL.NS
More research on REMLIFE.BO
REMLIFE.BO technical analysis REMLIFE.BO TheEdge Score Compare against peers
Open full interactive analysis & DCF →